A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma

PHASE3RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 11, 2023

Primary Completion Date

February 1, 2028

Study Completion Date

May 30, 2028

Conditions
Asthma
Interventions
DRUG

QMF149

QMF149 75/40 μg o.d via Breezhaler

DRUG

Budesonide

Budesonide 200 μg o.d via Breezhaler

Trial Locations (59)

1033

RECRUITING

Novartis Investigative Site, Budapest

2000

RECRUITING

Novartis Investigative Site, Rosario

2100

RECRUITING

Novartis Investigative Site, Gödöllő

5020

RECRUITING

Novartis Investigative Site, Salzburg

5400

RECRUITING

Novartis Investigative Site, Sevlievo

5500

RECRUITING

Novartis Investigative Site, Mendoza

6529

RECRUITING

Novartis Investigative Site, George

6720

RECRUITING

Novartis Investigative Site, Szeged

7002

RECRUITING

Novartis Investigative Site, Rousse

7130

RECRUITING

Novartis Investigative Site, Cape Town

7531

RECRUITING

Novartis Investigative Site, Cape Town

7700

RECRUITING

Novartis Investigative Site, Cape Town

7900

RECRUITING

Novartis Investigative Site, Szigetvár

8036

RECRUITING

Novartis Investigative Site, Graz

8185

RECRUITING

Novartis Investigative Site, Panama City

9301

RECRUITING

Novartis Investigative Site, Bloemfontein

14004

RECRUITING

Novartis Investigative Site, Córdoba

25123

RECRUITING

Novartis Investigative Site, Brescia

27100

RECRUITING

Novartis Investigative Site, Pavia

28034

RECRUITING

Novartis Investigative Site, Madrid

29011

RECRUITING

Novartis Investigative Site, Málaga

44100

RECRUITING

Novartis Investigative Site, Guadalajara

44130

RECRUITING

Novartis Investigative Site, Guadalajara

50139

RECRUITING

Novartis Investigative Site, Florence

76000

RECRUITING

Novartis Investigative Site, Querétaro

76800

RECRUITING

Novartis Investigative Site, San Juan del Río

80138

RECRUITING

Novartis Investigative Site, Napoli

86035

RECRUITING

Novartis Investigative Site, Villahermosa

95123

RECRUITING

Novartis Investigative Site, Catania

100000

RECRUITING

Novartis Investigative Site, Hanoi

300736

WITHDRAWN

Novartis Investigative Site, Timișoara

680001

RECRUITING

Novartis Investigative Site, Bucaramanga

700000

RECRUITING

Novartis Investigative Site, Ho Chi Minh City

730006

RECRUITING

Novartis Investigative Site, Ibagué

760001

RECRUITING

Novartis Investigative Site, Santiago de Cali

C1122AAK

RECRUITING

Novartis Investigative Site, CABA

C1414AIF

RECRUITING

Novartis Investigative Site, CABA

C1425BEN

RECRUITING

Novartis Investigative Site, CABA

S2000JKR

RECRUITING

Novartis Investigative Site, Rosario

A-3100

RECRUITING

Novartis Investigative Site, Sankt Pölten

301 00

RECRUITING

Novartis Investigative Site, Plzen Bory

128 08

RECRUITING

Novartis Investigative Site, Prague

124 62

RECRUITING

Novartis Investigative Site, Chaïdári

715 00

RECRUITING

Novartis Investigative Site, Heraklion Crete

265 04

RECRUITING

Novartis Investigative Site, Pátrai

546 42

RECRUITING

Novartis Investigative Site, Thessaloniki

01011

RECRUITING

Novartis Investigative Site, Guatemala City

01010

RECRUITING

Novartis Investigative Site, Guatemala City

00161

RECRUITING

Novartis Investigative Site, Roma

1649-035

RECRUITING

Novartis Investigative Site, Lisbon

4099-001

WITHDRAWN

Novartis Investigative Site, Porto

4100-180

RECRUITING

Novartis Investigative Site, Porto

050159

RECRUITING

Novartis Investigative Site, Bucharest

0009

RECRUITING

Novartis Investigative Site, Pretoria

0157

RECRUITING

Novartis Investigative Site, Raslouw Centurion

08950

RECRUITING

Novartis Investigative Site, Esplugues de Llobregat

08208

RECRUITING

Novartis Investigative Site, Sabadell

08035

RECRUITING

Novartis Investigative Site, Barcelona

04250

RECRUITING

Novartis Investigative Site, Haiphong

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY